ITA
ENGOriginal articles Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy
Original articles Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy
Current perspective New insights into the molecular basis of familial dilated cardiomyopathy
Current perspective New insights into the molecular basis of familial dilated cardiomyopathy
Current perspectives The molecular mechanisms of angiogenesis: a new approach to cardiovascular diseases
Current perspectives The molecular mechanisms of angiogenesis: a new approach to cardiovascular diseases
Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke
Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke
Myocardial viability in ischemic heart disease: new directions and perspectives
Myocardial viability in ischemic heart disease: new directions and perspectives
Editorial comment How cryptic is a cryptogenic stroke?
Editorial comment How cryptic is a cryptogenic stroke?
C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out
C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out
Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study
Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study
C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome
Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome
